Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile3 entries
2011
Harbin Pharmaceutical General Factory exposed over pollution and apologizes
Economic Information Daily reported in an investigation that the Harbin Pharmaceutical General Factory had long caused odor nuisance and wastewater discharge problems. The company apologized to the public for excessive emissions and denied some claims that its environmental protection investment was lower than its advertising investment. Progress: media investigation and company response. Entities involved: Harbin Pharmaceutical Group General Pharmaceutical Factory. Scope: Harbin Pharmaceutical Group General Pharmaceutical Factory.
2011
Harbin Pharmaceutical General Factory pollution exposed: “advertising spend 27 times environmental protection”
In June 2011, CCTV and other media exposed that the Harbin Pharmaceutical Group General Pharmaceutical Factory had long illegally discharged wastewater, waste gas, and solid waste; nearby residents were severely affected by the stench, and its advertising investment was 27 times its environmental protection investment, causing a public outcry. The Harbin environmental protection authorities subsequently fined it 1.23 million yuan, and the penalty was criticized as “a brickbat.” From 2015 to 2017 it was still continuously included on the key monitoring list. Harbin Pharmaceutical pledged to rectify the problems and invest in pollution control.
2011
Illegal Drug Ads Exposed More Than a Dozen Times in Six Years
China News Service reported that Harbin Pharmaceutical's 五海瘿瘤丸, 微达康颗粒, 牛鲜茶 and other products were exposed more than a dozen times within six years for illegal advertising, involving unapproved ads, exaggerated efficacy, absolute claims, and promotion of prescription drugs in mass media; some products were suspended from sale or had their advertising approvals revoked. The company was repeatedly handled by drug regulatory authorities.